Home » Topics » BioWorld Science

BioWorld Science
RSS

Bristol Myers Squibb patents rotein-arginine deiminase type-4 inhibitors

Sep. 8, 2021

New CAPN2 inhibitors identified at Western University of Health Sciences

Sep. 8, 2021

Lilly discovers TYK2 JH2 domain ligands

Sep. 8, 2021

Bahcesehir University presents new apoptosis regulator Bcl-2 inhibitors

Sep. 8, 2021

Discovery of a potent nonopioid analgesic peptide, RgIA-5474

Sep. 8, 2021

OR2AT4 identified as a new therapeutic target in COPD

Sep. 8, 2021

Study of beta-arrestin isoforms may alter development of drugs targeting GPCRs

Sep. 8, 2021

LB-100 blocks METH-induced drug-seeking/taking behavior in mice

Sep. 8, 2021

Adaptimmune and Genentech collaborate on allogeneic cell therapies for cancer

Sep. 7, 2021

Insilico Medicine and University of Cambridge collaborate on protein liquid-liquid phase separation

Sep. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...